DI BELLA METHOD
>
DOCUMENTATION INDEX > MDB - Documents
Genomic structure and transcriptional regulation of the human somatostatin receptor type 2.
(30/05/2003)
Detail
[Recent studies on anti-angiogenesis in cancer therapy]
(30/05/2003)
Detail
Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer.
(30/05/2003)
Detail
Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer.
(30/05/2003)
Detail
A dose-finding study of lanreotide (a somatostatin analog) in patients with colorectal carcinoma.
(30/05/2003)
Detail
Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer.
(30/05/2003)
Detail
Hormone therapy of postoperative recurrent pancreatic carcinoma with octreotide and tamoxifen]
(30/05/2003)
Detail
Tetrabutylammonium: a selective blocker of the somatostatin-activated hyperpolarizing current in mouse AtT-20 corticotrophs.
(30/05/2003)
Detail
Thrombospondin-1 promotes alpha3beta1 integrin-mediated adhesion and neurite-like outgrowth and inhibits proliferation of small cell lung carcinoma cells.
(30/05/2003)
Detail
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels.
(30/05/2003)
Detail
Positron emission tomography (PET) and other nuclear medicine modalities in staging gastrointestinal cancer.
(30/05/2003)
Detail
Topology of the signal transduction of the G protein-coupled somatostatin receptor sst2 in human glioma cells.
(30/05/2003)
Detail
Surgical management of left-sided carcinoid heart disease.
(30/05/2003)
Detail
Treatment with cisplatin and etoposide in patients with neuroendocrine tumors.
(30/05/2003)
Detail
[Somatostatin analogue treatment for malignant hypercalcemia associated with advanced breast cancer]
(30/05/2003)
Detail